Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ujjal Kumar Mukherjee

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Plos One|April 12, 2021
Recommending encounters according to the sociodemographic characteristics of patient strata can reduce risks from type 2 diabetesHan Ye, Ujjal Kumar Mukherjee, Dilip Chhajed, et al.
Scientific Reports|October 6, 2022
Detecting and mitigating simultaneous waves of COVID-19 infectionsSebastian Souyris, Shuai Hao, Subhonmesh Bose, et al.
Iscience|January 23, 2024
COVID-19 test-to-stay program for K-12 schools: Opt-in versus opt-out consent modelAnton Ivanov, Ujjal Kumar Mukherjee, Subhonmesh Bose, et al.
Blood Cancer Journal|March 10, 2022
secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omicsHarish Kumar, Suman Mazumder, Sayak Chakravarti, et al.
Blood Cancer Journal|December 6, 2023
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myelomaAmit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Plos One|April 12, 2021
Recommending encounters according to the sociodemographic characteristics of patient strata can reduce risks from type 2 diabetesHan Ye, Ujjal Kumar Mukherjee, Dilip Chhajed, et al.
Scientific Reports|October 6, 2022
Detecting and mitigating simultaneous waves of COVID-19 infectionsSebastian Souyris, Shuai Hao, Subhonmesh Bose, et al.
Iscience|January 23, 2024
COVID-19 test-to-stay program for K-12 schools: Opt-in versus opt-out consent modelAnton Ivanov, Ujjal Kumar Mukherjee, Subhonmesh Bose, et al.
Blood Cancer Journal|March 10, 2022
secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omicsHarish Kumar, Suman Mazumder, Sayak Chakravarti, et al.
Blood Cancer Journal|December 6, 2023
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myelomaAmit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, et al.
Pageof 1